Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pluristem Therapeutc (PSTI)

Pluristem Therapeutc (PSTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pluristem Therapeutc MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 ISR

www.pluristem.com P: 972-74-710-8600

Description:

PLURISTEM THERAPEUTICS INC. is a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. The Company is developing a pipeline of products, stored ready-to-use, that are derived from the human placenta, a non-controversial source, and not from embryonic stem cells.

Key Statistics

Overview:

Market Capitalization, $K 32,348
Enterprise Value, $K 32,347
Shares Outstanding, K 32,348
Annual Sales, $ 0 K
Annual Net Income, $ -49,870 K
Last Quarter Sales, $ 230 K
Last Quarter Net Income, $ -9,860 K
60-Month Beta 1.91
% of Insider Shareholders 5.40%
% of Institutional Shareholders 16.94%
Float, K 30,601
% Float 94.60%
Short Volume Ratio 0.13

Growth:

1-Year Return -70.85%
3-Year Return -80.69%
5-Year Return -90.99%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 38.97%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 05/09/22
Latest Earnings Date 09/12/22
Earnings Per Share ttm -1.47
EPS Growth vs. Prev Qtr 8.82%
EPS Growth vs. Prev Year 35.42%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/25/19

PSTI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -100.63%
Return-on-Assets % -55.46%
Profit Margin % 0.00%
Debt/Equity 0.57
Price/Sales 136.79
Price/Cash Flow N/A
Price/Book 0.80
Book Value/Share 1.25
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar